Medarex (MEDX) calls active as shares up on prostate cancer treatment report
Tweet Send to a Friend
Medarex (Nasdaq: MEDX) : Medarex is recently up $1.26 to $8.61. The Mayo Clinic online publication ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
